Calendar Beximco Pharmaceuticals Limited

Equities

End-of-day quote Dhaka S.E. Other stock markets 23:00:00 24/04/2024 BST			5-day change	1st Jan Change
116.1 ^BDT	-0.43%		-1.36%	-20.59%

03-04	Beximco names Iqbal Ahmed as managing director	AN
01-30	Beximco Pharmaceuticals to strengthen portfolio as interim profit up	AN

2.IEH4GaVWlMVCzN_Uf2XFvEwoYp3LmIDFQEAAlRjNfUg.Ti3PW5YR8YMlvfKeTQuX-xZeFLCB2diUdgli1HS8RCV1cp8o4zej_Bu-vA~a62c546121020e6ae3645b2380f18316

06/11/2024	Q1 2025 Earnings Release (Projected)
11/11/2024	Q4 2024 Earnings Release (Projected)
28/01/2025	Q2 2025 Earnings Release (Projected)

25/04/2024	Q3 2024 Earnings Release (Projected)
30/01/2024 07:00	Q2 2024 Earnings Release
28/12/2023 10:30	Annual General Meeting
13/11/2023	Ex-dividend day for final dividend
06/11/2023 07:00	Q1 2024 Earnings Release
20/10/2023 07:00	Q4 2023 Earnings Release
02/05/2023 07:00	Q3 2023 Earnings Release
30/01/2023 07:00	Interim 2023 Earnings Release
22/12/2022 04:30	Annual General Meeting
21/11/2022	Ex-dividend day for final dividend
11/11/2022 07:00	Q1 2023 Earnings Release
28/10/2022 07:00	FY 2022 Earnings Release
28/04/2022 07:00	Q3 2022 Earnings Release
28/01/2022 07:00	Interim 2022 Earnings Release
23/12/2021 04:30	Annual General Meeting
22/11/2021	Ex-dividend day for final dividend
11/11/2021 10:30	Q1 2022 Earnings Release
02/11/2021 07:00	FY 2021 Earnings Release
29/04/2021	Q3 2021 Earnings Release
28/01/2021 07:00	Interim 2021 Earnings Release

Fiscal Period	June	2019	2020	2021	2022	2023	2024
Net sales Million BDT	Released Forecast Spread	22 817 22 373 1.98%	25 612 25 468 0.57%	29 494 29 285 0.71%	34 669 34 396 0.79%	39 267 38 191 2.82%	44 551
EBITDA Million BDT	Released Forecast Spread	6 009 5 759 4.34%	6 723 6 464 4.01%	7 765 8 132 -4.51%	8 543 8 951 -4.56%	0,00 0,00 -	9 785
EBIT Million BDT	Released Forecast Spread	5 066 4 786 5.85%	5 609 5 348 4.9%	6 651 7 029 -5.38%	6 901 7 780 -11.29%	7 216 7 297 -1.11%	7 905
Earnings before Tax (EBT) Million BDT	Released Forecast Spread	3 946 3 856 2.34%	4 653 4 470 4.1%	6 378 6 726 -5.18%	6 687 8 306 -19.49%	6 069 6 645 -8.67%	6 915
Net income Million BDT	Released Forecast Spread	3 033 2 941 3.14%	3 515 3 395 3.54%	5 141 5 011 2.59%	5 123 6 387 -19.79%	4 612 5 151 -10.47%	5 132
EPS BDT	Released Forecast Spread	6,80 6,64 2.47%	7,88 7,59 3.87%	11,5 11,2 2.32%	11,5 12,3 -6.67%	10,3 0,00 -	12,3
Announcement Date		11/11/19	11/11/20	02/11/21	08/11/22	01/11/23	-

28/04/2024	SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024	SHOUYAO HOLDINGS (BEIJING) CO., LTD.: Q4 2023 Earnings Release
28/04/2024	BEIJING AOSAIKANG PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024	JIANGXI FUSHINE PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024	AURISCO PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
28/04/2024	PT TEMPO SCAN PACIFIC TBK: Q1 2024 Earnings Release (Projected)
28/04/2024	SICHUAN HUIYU PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024	ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
28/04/2024	ZHEJIANG HISOAR PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
28/04/2024	WEDGE INDUSTRIAL CO.,LTD.: Q1 2024 Earnings Release

26/04/2024	LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q4 2023 Earnings Release
26/04/2024	NANJING VAZYME BIOTECH CO.,LTD: Q4 2023 Earnings Release
26/04/2024	LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD.: Q1 2024 Earnings Release
26/04/2024	HUNAN ER-KANG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release
26/04/2024	ZHUHAI RUNDU PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
26/04/2024	GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release
26/04/2024	GUIZHOU SANLI PHARMACEUTICAL CO.,LTD: Q4 2023 Earnings Release
26/04/2024	NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO.,LTD.: Q1 2024 Earnings Release
26/04/2024	ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
26/04/2024	ZHEJIANG AUSUN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release